Literature DB >> 19458545

Mitochondrial and axonal abnormalities precede disruption of the neurofilament network in a model of charcot-marie-tooth disease type 2E and are prevented by heat shock proteins in a mutant-specific fashion.

Miranda L Tradewell1, Heather D Durham, Walter E Mushynski, Benoit J Gentil.   

Abstract

Mutations in NEFL encoding the light neurofilament subunit (NFL) cause Charcot-Marie-Tooth disease type 2E (CMT2E), which affects both motor and sensory neurons. We expressed the disease-causing mutants NFL and NFL in motor neurons of dissociated spinal cord-dorsal root ganglia and demonstrated that they are incorporated into the preexisting neurofilament network but eventually disrupt neurofilaments without causing significant motor neuron death. Importantly, rounding of mitochondria and reduction in axonal diameter occurred before disruption of the neurofilament network, indicating that mitochondrial dysfunction contributes to the pathogenesis of CMT2E, as well as to CMT caused by mitofusin mutations. Heat shock proteins (HSPs) are involved in the formation of the neurofilament network and in protecting cells from misfolded mutant proteins. Cotransfection of HSPB1 with mutated NEFL maintained the neurofilament network, axonal diameter, and mitochondrial length in motor neurons expressing NFL, but not NFL. Conversely, HSPA1 cotransfection was effective in motor neurons expressing NFL, but not NFL. Thus, there are NFL mutant-specific differences in the ability of individual HSPs to prevent neurofilament abnormalities, reduction in axonal caliber, and disruption of mitochondrial morphology in motor neurons. These results suggest that HSP inducers have therapeutic potential for CMT2E but that their efficacy would depend on the profile of HSPs induced and the type of NEFL mutation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458545     DOI: 10.1097/NEN.0b013e3181a5deeb

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  17 in total

Review 1.  Mitochondria: the next (neurode)generation.

Authors:  Eric A Schon; Serge Przedborski
Journal:  Neuron       Date:  2011-06-23       Impact factor: 17.173

2.  Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E.

Authors:  Chiara Pisciotta; Yunhong Bai; Kathryn M Brennan; Xingyao Wu; Tiffany Grider; Shawna Feely; Suola Wang; Steven Moore; Carly Siskind; Michael Gonzalez; Stephan Zuchner; Michael E Shy
Journal:  Neurology       Date:  2015-06-24       Impact factor: 9.910

3.  Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex.

Authors:  Albert Misko; Sirui Jiang; Iga Wegorzewska; Jeffrey Milbrandt; Robert H Baloh
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

4.  Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with age.

Authors:  Judith Eschbach; Jérôme Sinniger; Jamal Bouitbir; Anissa Fergani; Anna-Isabel Schlagowski; Joffrey Zoll; Bernard Geny; Frédérique René; Yves Larmet; Vincent Marion; Robert H Baloh; Matthew B Harms; Michael E Shy; Nadia Messadeq; Patrick Weydt; Jean-Philippe Loeffler; Albert C Ludolph; Luc Dupuis
Journal:  Neurobiol Dis       Date:  2013-06-04       Impact factor: 5.996

5.  Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.

Authors:  Adijat A Adebola; Theo Di Castri; Chui-Zhen He; Laura A Salvatierra; Jian Zhao; Kristy Brown; Chyuan-Sheng Lin; Howard J Worman; Ronald K H Liem
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

6.  HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease.

Authors:  Constantin d'Ydewalle; Jyothsna Krishnan; Driss M Chiheb; Philip Van Damme; Joy Irobi; Alan P Kozikowski; Pieter Vanden Berghe; Vincent Timmerman; Wim Robberecht; Ludo Van Den Bosch
Journal:  Nat Med       Date:  2011-07-24       Impact factor: 53.440

Review 7.  Intermediate Charcot-Marie-Tooth disease.

Authors:  Lei Liu; Ruxu Zhang
Journal:  Neurosci Bull       Date:  2014-10-17       Impact factor: 5.203

8.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

9.  Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease.

Authors:  Robert D S Pitceathly; Sinéad M Murphy; Ellen Cottenie; Annapurna Chalasani; Mary G Sweeney; Cathy Woodward; Ese E Mudanohwo; Iain Hargreaves; Simon Heales; John Land; Janice L Holton; Henry Houlden; Julian Blake; Michael Champion; Frances Flinter; Stephanie A Robb; Rupert Page; Michael Rose; Jacqueline Palace; Carol Crowe; Cheryl Longman; Michael P Lunn; Shamima Rahman; Mary M Reilly; Michael G Hanna
Journal:  Neurology       Date:  2012-08-29       Impact factor: 9.910

10.  Inherited neuropathies.

Authors:  Angelo Schenone; Lucilla Nobbio; Margherita Monti Bragadin; Giulia Ursino; Marina Grandis
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.